Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21034083 | 0.78 | RECQL (0.44) | KMT2ARECQLSMN1; SMN2POLBHTT | |
| SCHEMBL8148844 | 0.77 | RECQL (0.46) | KMT2ARECQLSMN1; SMN2POLBHTT | |
| SCHEMBL27700919 | 0.77 | KMT2A (0.42) | KMT2ARECQLSMN1; SMN2POLBHTT | |
| SCHEMBL16508785 | 0.77 | TSHR (0.47) | KMT2ASMN1; SMN2TSHRALDH1A1CA12 | |
| SCHEMBL21493577 | 0.76 | MCL1 (0.30) | — | |
| SCHEMBL15041407 | 0.75 | RECQL (0.45) | KMT2ARECQLSMN1; SMN2POLBHTT | |
| SCHEMBL5535962 | 0.75 | ESR1 (0.42) | KDM4EALDH1A1CA12CA1CA2 | |
| SCHEMBL28944437 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL28623166 | 0.74 | — | — | |
| SCHEMBL28827551 | 0.74 | RECQL (0.44) | KMT2ARECQLSMN1; SMN2POLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118878466-A | Trifluoro-azole and its preparation method | 特里纳普克公司 | 2024-11-01 | — | — | CN | claimed |
| EP-4097089-A1 | TRIFLAZOLES AND METHODS OF MAKING THE SAME | Trinapco, Inc (US) | 2022-12-07 | — | — | EP | claimed |
| CN-115038692-A | Trifluozole and preparation method thereof | 特里纳普克公司 | 2022-09-09 | — | — | CN | claimed |
| US-11242322-B2 | Triflazoles and methods of making the same | TRINAPCO, INC. (US) | 2022-02-08 | — | — | US | claimed |
| WO-2021154345-A1 | TRIFLAZOLES AND METHODS OF MAKING THE SAME | TRINAPCO, INC. (US) | 2021-08-05 | — | — | WO | claimed |
| US-20210238142-A1 | TRIFLAZOLES AND METHODS OF MAKING THE SAME | TRINAPCO, INC. (US) | 2021-08-05 | — | — | US | claimed |
| US-20250289781-A1 | TRIFLUOROMETHANESULFONYLATING AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANESULFONYL COMPOUND | CENTRAL GLASS COMPANY, LIMITED (JP) | 2025-09-18 | — | — | US | disclosed |
| CN-119137096-A | Trifluoromethanesulfonyl a composition of the agent trifluoromethanesulfonyl oxy compounds or Process for producing trifluoromethanesulfonyl compound | 中央硝子株式会社 | 2024-12-13 | — | — | CN | disclosed |
| CN-118878466-A | Trifluoro-azole and its preparation method | 特里纳普克公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-115038692-B | Trifluoro-azole and its preparation method | 特里纳普克公司 | 2024-07-16 | — | — | CN | disclosed |
| WO-2023214552-A1 | TRIFLUOROMETHANE SULFONYLATION AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANE SULFONYL COMPOUND | セントラル硝子株式会社 | 2023-11-09 | — | — | WO | disclosed |
| WO-2023214552-A1 | TRIFLUOROMETHANE SULFONYLATION AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANE SULFONYL COMPOUND | セントラル硝子株式会社 | 2023-11-09 | — | — | WO | disclosed |
| EP-4097089-A1 | TRIFLAZOLES AND METHODS OF MAKING THE SAME | Trinapco, Inc (US) | 2022-12-07 | — | — | EP | disclosed |
| CN-115038692-A | Trifluozole and preparation method thereof | 特里纳普克公司 | 2022-09-09 | — | — | CN | disclosed |
| US-11242322-B2 | Triflazoles and methods of making the same | TRINAPCO, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| WO-2021154345-A1 | TRIFLAZOLES AND METHODS OF MAKING THE SAME | TRINAPCO, INC. (US) | 2021-08-05 | — | — | WO | disclosed |
| US-20210238142-A1 | TRIFLAZOLES AND METHODS OF MAKING THE SAME | TRINAPCO, INC. (US) | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289781-A1 | TRIFLUOROMETHANESULFONYLATING AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANESULFONYL COMPOUND | AFF1, BRAF, AFF2 | KMT2A 774/4885RECQL 3948/4885SMN1; SMN2 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.